Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety
Marc Schmalzing, Ayman Askari, Giampiero Girolomoni, Julio C. V. Perez-Coleman, Cristofer Salvati, Elena Bachinskaya
Springer Nature ·
2025-11-18
· DOI 10.1007/s12325-025-03367-5
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Marc Schmalzing, Ayman Askari, Giampiero Girolomoni, Julio C. V. Perez-Coleman, Cristofer Salvati, Elena Bachinskaya. Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety. // Advances in Therapy. – 2025. – DOI: 10.1007/s12325-025-03367-5. – URL: https://doi.org/10.1007/s12325-025-03367-5
Marc Schmalzing, Ayman Askari, Giampiero Girolomoni, Julio C. V. Perez-Coleman, Cristofer Salvati, & Elena Bachinskaya (2025). Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety. Advances in Therapy. https://doi.org/10.1007/s12325-025-03367-5
Marc Schmalzing, et al. “Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety.” Advances in Therapy, 2025. doi:10.1007/s12325-025-03367-5.
@article{Schmalzing2025,
title = {Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety},
author = {Schmalzing, Marc and Askari, Ayman and Girolomoni, Giampiero and Perez-Coleman, Julio C. V. and Salvati, Cristofer and Bachinskaya, Elena},
journal = {Advances in Therapy},
year = {2025},
doi = {10.1007/s12325-025-03367-5},
url = {https://doi.org/10.1007/s12325-025-03367-5}
}